The utility of spliceosome-mediated RNA trans-splicing as an RNA-based technology has been proven in vitro studies and in preclinical disease models, including cystic fibrosis (CF) [24-26], haemophilia A [27], and X-linked immunodeficiency with hyper IgM (HIGM1) [28]. Here, CD40LG is linked to cystic fibrosis.